Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The current drug discovery landscape for trypanosomiasis and leishmaniasis: Challenges and strategies to identify drug targets

6 Apr 2020

Abstract excerpt

Human trypanosomiasis and leishmaniasis are vector-borne neglected tropical diseases caused by infection with the protozoan parasites Trypanosoma spp. and Leishmania spp., respectively. Once restricted to endemic areas, these diseases are now distributed worldwide due to human migration, climate change, and anthropogenic disturbance, causing significant health and economic burden globally. The current...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Parasites and Host Interactions
Share to Research on Leishmaniasis Studies
Share to Trypanosoma species research and implications

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32249457
DOI: 10.1002/ddr.21664

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The current drug discovery landscape for trypanosomiasis and leishmaniasis: Challenges and strategies to identify drug targetsPMID 32249457Read ↗

Genetically Validated Drug Targets in Leishmania: Current Knowledge and Future ProspectsSemantic proximity Read ↗

A Brief Review of Drug Discovery Research for Human African TrypanosomiasisSemantic proximity Read ↗

Of Drugs and Trypanosomatids: New Tools and Knowledge to Reduce Bottlenecks in Drug DiscoverySemantic proximity Read ↗

DRUG DISCOVERY AND DEVELOPMENT FOR NEGLECTED TROPICAL DISEASESSemantic proximity Read ↗

The critical role of mode of action studies in kinetoplastid drug discoverySemantic proximity Read ↗

State‐of‐the‐art CRISPR /Cas9 Technology for Genome Editing in TrypanosomatidsSemantic proximity Read ↗

Emerging therapeutic targets for treatment of leishmaniasisSemantic proximity Read ↗

Antiparasitic chemotherapy: from genomes to mechanisms.Semantic proximity Read ↗

Genome-wide RNAi screens in bloodstream form trypanosomes identify drug transportersSemantic proximity Read ↗

Potential therapeutic targets and the role of technology in developing novel antileishmanial drugs.Semantic proximity Read ↗

Kinetoplastid diseases: Insights into the mechanisms of drug action and resistance for novel drug discoverySemantic proximity Read ↗

Drug discovery for neglected diseases: molecular target-based and phenotypic approaches.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.